Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

There is a telling part of the body that has given away Hollywood stars' more mature untreated complexions - especially when ...

A new daily pill that suppresses the appetite has been shown to help patients lose weight in clinical trials.

Onlookers are questioning if Oprah Winfrey and Sharon Osbourne might be experiencing what's being dubbed “Ozempic feet.” ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

The first weight loss pill to suppress appetite has been shown to work in clinical trials, offering a ray of hope to the 40% ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

The two Slaton sisters have been on years-long weight loss journeys, which have been chronicled on TLC’s 1,000-Lbs Sisters ...

Lilly, which makes weight loss injections, unveils trial result showing Type 2 diabetes sufferers lost 8% of body weight ...